---All---
  • ---All---
  • Accession
  • Catalog #

ACVR1B AntibodyPeptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP12925a 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP12925a-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

ACVR1B Antibody - Product info

ApplicationWB, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP36896
Other AccessionNP_004293.1, NP_064733.3
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW56807 Da

ACVR1B Antibody - Additional info

Gene ID 91
Other Names
ACVR1B; ACVRLK4; ALK4; Activin receptor type-1B; Activin receptor type IB; Activin receptor-like kinase 4; Serine/threonine-protein kinase receptor R2
Target/Specificity
This ACVR1B antibody is generated from rabbits immunized with a recombinant protein from human ACVR1B.
Dilution
WB~~1:100~500
IHC~~1:10~50
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
ACVR1B Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

ACVR1B Antibody - Protein Information

Name ACVR1B
Synonyms ACVRLK4, ALK4
Function
Transmembrane serine/threonine kinase activin type-1 receptor forming an activin receptor complex with activin receptor type-2 (ACVR2A or ACVR2B). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating a many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, type-2 receptors (ACVR2A and/or ACVR2B) act as a primary activin receptors whereas the type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine- threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor such as ACVR1B Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C- terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor. ACVR1B also phosphorylates TDP2
Cellular Location
Cell membrane; Single-pass type I membrane protein (By similarity)
Tissue Location
Expressed in many tissues, most strongly in kidney, pancreas, brain, lung, and liver

ACVR1B Antibody - Related products

AM1863a: ACVR1B Antibody (Ascites)

AM1863b: ACVR1B Antibody

AP12925a: ACVR1B Antibody

AP7801a: Activin A Receptor Type IB (ACVR1B) Antibody (N-term)

AP7801c: Activin A Receptor Type IB (ACVR1B) Antibody (Center)

RI10098: ACVR1B predesign siRNA

DC00105: Human ACVR1B cDNA Clone

LY11040a: ACVR1B Over-expression Lysate

BP7801a: ACVR1B Antibody (N-term) Blocking Peptide

BP7801c: ACVR1B Antibody (Center) Blocking Peptide

ACVR1B Antibody - Application data

  • Western blot analysis of ACVR1B (arrow) using rabbit polyclonal ACVR1B Antibody (Cat. #AP12925a). 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the ACVR1B gene.

  • ACVR1B Antibody (Cat. #AP12925a)immunohistochemistry analysis in formalin fixed and paraffin embedded human kidney tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of ACVR1B Antibody for immunohistochemistry. Clinical relevance has not been evaluated.

ACVR1B Antibody - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes an activin A type IB receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I and two type II receptors. This protein is a type I receptor which is essential for signaling. Mutations in this gene are associated with pituitary tumors. Alternate splicing results in multiple transcript variants.

REFERENCES

Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Suzuki, K., et al. Biochem. Biophys. Res. Commun. 394(3):639-645(2010) Calvanese, L., et al. J. Pept. Sci. 15(3):175-183(2009) Esguerra, C.V., et al. Development 134(24):4381-4393(2007) Maguire, P.B., et al. Proteomics 2(6):642-648(2002)